Literature DB >> 22591262

Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.

Li Zhou1, Kai Li, Yu-Ling Shi, Iltefat Hamzavi, Tian-Wen Gao, Marsha Henderson, Richard H Huggins, Oma Agbai, Bassel Mahmoud, Xiaofan Mi, Henry W Lim, Qing-Sheng Mi.   

Abstract

Although it is widely believed that non-segmental vitiligo (NSV) results from the autoimmune destruction of melanocytes, a clear understanding of defects in immune tolerance, which mediate this uncontrolled self-reactivity, is still lacking. In the present study, we systemically evaluated circulating regulatory T (Treg) cells, including CD4(+) CD25(+) FoxP3(+) Treg cells and invariant natural killer T (iNKT) cells, as well as naïve and memory CD4(+) and CD8(+) T cells and their cytokine production, in a cohort of 43 progressive NSV patients with race-, gender-, and age-matched healthy controls. We found that the general immunophenotypes of CD4(+) and CD8(+) T cells and the percentage of CD4(+) CD25(+) FoxP3(+) Tregs were comparable between NSV and healthy controls. However, percentages of peripheral iNKT cells were significantly decreased in NSV patients compared to that in healthy controls. Our data confirm the previous notion that the percentage of peripheral CD4(+) CD25(+) FoxP3(+) Tregs remains unaltered in NSV and suggests the involvement of defective iNKT cells in the pathogenesis of NSV.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591262      PMCID: PMC3801166          DOI: 10.1111/j.1755-148X.2012.01019.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  57 in total

1.  Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.

Authors:  M Ben Ahmed; I Zaraa; R Rekik; A Elbeldi-Ferchiou; N Kourda; N Belhadj Hmida; M Abdeladhim; O Karoui; A Ben Osman; M Mokni; H Louzir
Journal:  Pigment Cell Melanoma Res       Date:  2011-10-25       Impact factor: 4.693

2.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

3.  NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.

Authors:  V Laloux; L Beaudoin; D Jeske; C Carnaud; A Lehuen
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

4.  Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage.

Authors:  H J van der Vliet; B M von Blomberg; N Nishi; M Reijm; A E Voskuyl; A A van Bodegraven; C H Polman; T Rustemeyer; P Lips; A J van den Eertwegh; G Giaccone; R J Scheper; H M Pinedo
Journal:  Clin Immunol       Date:  2001-08       Impact factor: 3.969

5.  Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.

Authors:  Yorihisa Kotobuki; Atsushi Tanemura; Lingli Yang; Saori Itoi; Mari Wataya-Kaneda; Hiroyuki Murota; Minoru Fujimoto; Satoshi Serada; Tetsuji Naka; Ichiro Katayama
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-10       Impact factor: 4.693

6.  Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.

Authors:  B Palermo; R Campanelli; S Garbelli; S Mantovani; E Lantelme; V Brazzelli; M Ardigó; G Borroni; M Martinetti; C Badulli; A Necker; C Giachino
Journal:  J Invest Dermatol       Date:  2001-08       Impact factor: 8.551

7.  Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.

Authors:  P Y Basak; A K Adiloglu; I G Koc; T Tas; V B Akkaya
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-05-08       Impact factor: 6.166

8.  Th17 cells and activated dendritic cells are increased in vitiligo lesions.

Authors:  Claire Q F Wang; Andres E Cruz-Inigo; Judilyn Fuentes-Duculan; Dariush Moussai; Nicholas Gulati; Mary Sullivan-Whalen; Patricia Gilleaudeau; Jules A Cohen; James G Krueger
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

9.  Reduced skin homing by functional Treg in vitiligo.

Authors:  Jared Klarquist; Cecele J Denman; Claudia Hernandez; Derek A Wainwright; Derek J Wainwright; Faith M Strickland; Andreas Overbeck; Shikar Mehrotra; Michael I Nishimura; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2010-02-19       Impact factor: 4.693

10.  Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.

Authors:  Anna Wańkowicz-Kalińska; René M J G J van den Wijngaard; Bert J Tigges; Wiete Westerhof; Graham S Ogg; Vincenzo Cerundolo; Walter J Storkus; Pranab K Das
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

View more
  14 in total

Review 1.  Understanding mechanisms of autoimmunity through translational research in vitiligo.

Authors:  James P Strassner; John E Harris
Journal:  Curr Opin Immunol       Date:  2016-10-17       Impact factor: 7.486

Review 2.  Innate immune mechanisms in vitiligo: danger from within.

Authors:  Jillian M Richmond; Michael L Frisoli; John E Harris
Journal:  Curr Opin Immunol       Date:  2013-11-12       Impact factor: 7.486

3.  Natural killer T cell based Immunotherapy.

Authors:  Priyanka B Subrahmanyam; Wenji Sun; James E East; Junxin Li; Tonya J Webb
Journal:  J Vaccines Vaccin       Date:  2012-08-23

Review 4.  Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Authors:  Zhussipbek Mukhatayev; Yekaterina O Ostapchuk; Deyu Fang; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2021-01-18       Impact factor: 17.390

Review 5.  Vitiligo--part 1.

Authors:  Roberto Gomes Tarlé; Liliane Machado do Nascimento; Marcelo Távora Mira; Caio Cesar Silva de Castro
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

6.  HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.

Authors:  Qian Zhang; Tingting Cui; Yuqian Chang; Weigang Zhang; Shuli Li; Yuanmin He; Bing Li; Ling Liu; Gang Wang; Tianwen Gao; Chunying Li; Zhe Jian
Journal:  J Cell Mol Med       Date:  2018-07-05       Impact factor: 5.310

7.  Immunophenotype of circulatory T-helper cells in patients with non-segmental vitiligo.

Authors:  Rajendiran Kalaiselvi; Medha Rajappa; Laxmisha Chandrasekhar; Devinder M Thappa; Priyadarssini Munisamy
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

8.  Genetic parameters and genome-wide association study of hyperpigmentation of the visceral peritoneum in chickens.

Authors:  Chenglong Luo; Hao Qu; Jie Wang; Yan Wang; Jie Ma; Chunyu Li; Chunfen Yang; Xiaoxiang Hu; Ning Li; Dingming Shu
Journal:  BMC Genomics       Date:  2013-05-16       Impact factor: 3.969

9.  FOXP3 is a promising and potential candidate gene in generalised vitiligo susceptibility.

Authors:  Parveen Jahan; Surekha Tippisetty; Prasanna L Komaravalli
Journal:  Front Genet       Date:  2015-07-22       Impact factor: 4.599

Review 10.  Concise review of recent studies in vitiligo.

Authors:  Mohamed Allam; Hassan Riad
Journal:  Qatar Med J       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.